Concurrent Pneumocystis jirovecii pneumonia and Guillain-Barre syndrome after surgery and adjuvant chemoradiotherapy for stage IIIA lung adenocarcinoma: a case report and literature review
This case report describes a rare instance of concurrent Pneumocystis jirovecii pneumonia and Guillain-Barré syndrome in a lung cancer patient following chemoradiotherapy, emphasizing the critical need for early, multi-modal diagnostic assessment to distinguish overlapping infectious and immune-mediated complications from treatment-related toxicity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine your body's immune system as a highly trained security team guarding a fortress (your lungs). Usually, this team is ready to fight off any intruder. But sometimes, the fortress itself needs major repairs—like surgery and powerful chemical treatments (chemotherapy and radiation) to remove a dangerous tumor. In this story, a 62-year-old woman underwent exactly that: she had a tumor removed from her left lung and then received four rounds of chemotherapy plus radiation therapy.
The Great Security Breakdown
Think of the immune system's "soldiers" as different types of guards. The most important ones for spotting sneaky invaders are the CD4+ guards. In a healthy person, there are hundreds of these guards per drop of blood. But after the heavy treatments, this woman's security team was decimated. Her blood test showed she had only 49 CD4+ cells per µL. That's like leaving the fortress gates wide open with almost no guards left.
The Double Trouble: Sneaky Invaders and a Friendly Fire Accident
With the gates open, two very different problems happened at the same time, creating a confusing medical mystery.
The Sneaky Invaders (PJP and Mixed Infection):
Usually, a specific fungus called Pneumocystis jirovecii (PJP) only attacks people with HIV. But in this case, because the security team was so weak, this fungus invaded her lungs anyway. It wasn't alone, though. It brought along other troublemakers: a bacteria called Mycobacterium abscessus, another bacteria called Pseudomonas aeruginosa, and some viruses.- The Clue: Doctors couldn't just look at her X-ray and say, "Ah, that's PJP!" because her lungs had already been changed by surgery and fluid buildup, hiding the usual "foggy" signs of the infection. They had to use a special high-tech scanner (called metagenomic next-generation sequencing) on fluid from her lungs. This scanner found 476 "reads" (digital fingerprints) of the PJP fungus, along with the other bacteria.
- The Result: She got very sick, with a fever and such low oxygen that her blood oxygen level dropped to 30% (which is dangerously low). She needed a breathing machine to survive.
The Friendly Fire Accident (Guillain-Barré Syndrome):
While her body was fighting the invaders, her immune system got so confused that it started attacking its own wiring. This is called Guillain-Barré syndrome (GBS). Imagine the immune system, instead of fighting the bad guys, accidentally started cutting the electrical cables that tell her muscles to move.- The Clue: She suddenly couldn't move her arms or legs well. Her arm strength dropped to grade 3 (she could move them against gravity but not much else), and her legs dropped to grade 2 (she could only move them if gravity was removed).
- The Proof: Doctors tested the fluid around her brain and found a specific chemical imbalance (high protein, normal white blood cells). They also used a machine to check her nerves, which showed severe damage to the "motor axons" (the wires that make muscles move). This confirmed she had a specific, severe type of GBS.
The Rescue Mission
The doctors realized they were dealing with a "double whammy." They couldn't just treat the infection or just treat the nerve problem; they had to do both at once.
- For the Invaders: They switched her antibiotics to a special combination called trimethoprim-sulfamethoxazole to kill the fungus, plus other strong drugs to fight the bacteria.
- For the Nerves: They gave her a massive dose of "immune helpers" (intravenous immunoglobulin, or IVIG) to calm down the confused immune system.
- The Outcome: It worked. After 20 days in the intensive care unit, she was taken off the breathing machine. By December 26, 2025, she was awake, her oxygen levels were back to normal (98%), and her muscles were strong enough to move on their own (grade 4). She went home to continue rehab.
What This Story Teaches Us
This case suggests a very important lesson for doctors: If a cancer patient who has had surgery and radiation suddenly gets a fever, can't breathe well, and doesn't get better with normal antibiotics, don't just assume it's a regular pneumonia. They might have a rare fungus like PJP, even if the X-ray looks weird.
Furthermore, if that same patient suddenly gets weak in their limbs or has trouble swallowing, it might not just be because they are tired or sick. It could be their immune system attacking their nerves (GBS). The paper suggests that doctors need to check the immune cells, scan the lungs deeply, and test the nerves all at the same time to solve these tricky puzzles quickly.
What the Paper Says It's NOT
The authors are careful to say that this isn't a "cure" or a guaranteed rule for everyone. They note that their data had some small inconsistencies (like a few numbers in the blood gas records that didn't quite match up) and they didn't test for every single possible antibody. They also point out that the "foggy" look on the X-ray, which usually screams "PJP," was completely hidden in this case by her previous surgery and fluid. So, just because an X-ray looks normal doesn't mean the infection isn't there.
The Bottom Line
This is a story about a patient who survived a perfect storm of a weakened immune system, a rare fungal infection, and a nerve-attacking syndrome. It suggests that when cancer treatments weaken the body's defenses too much, strange and overlapping problems can happen, and catching them early with the right tests is the only way to win the battle.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.